Colorectal Cancer Market Segmented by Product, Top Manufacturers, Geography Trends & Forecasts to 2026
Global Colorectal Cancer Market by Manufacturers, Countries, Type and Application, forecast to 2026 Report Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segment
(EMAILWIRE.COM, October 13, 2018 ) The Global Colorectal Cancer Market Size will gain traction due to the factors such as technological advancements for developing therapies that would be effective in treating this type of cancer.
Colorectal cancer starts from colon, and is also referred as colon cancer. The cancer cells grow in the inner lining of colon or rectum and these cells are known as polyps. Generally, there are five types of colon cancer namely; Adenocarcinomas, carcinoid tumours, gastrointestinal stromal tumours, lymphomas, and sarcomas. Adenocarcinomas is the most common type of colon cancer that makes up 96% of total colon cancer.
The colorectal cancer spreads into lymph nodes that can be treated with surgical treatment followed by chemotherapy. Colorectal cancer is characterised by bleeding from back passage, losing weight, and pain in your abdomen or back passage. Approximately, 50,000 people die due to this disease every year.
Request sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/request-for-free-sample
According to American Society of Clinical Oncology (ASCO), colorectal is the fourth most common type of cancer in the U.S. In 2017, the number of people suffering from colorectal cancer were 135, 430 adults in the U.S.
Technological advancements in the therapies like chemotherapy to boost the colorectal cancer market.
The colorectal cancer market is primarily driven by the increasing adoption of western diets globally. These diets contain high fats and low fibres leading to the formation of polyps in the colon or rectum. On the other hand, the increasing awareness for treating colorectal cancer by chemotherapy and immunotherapy would also propel the industry growth during the forecast period. While, rise in the aging population, and increasing awareness of consumers in the developing countries will also boost the colorectal market.
However, higher cost of the available treatments, less awareness for ongoing screening test of drugs, and expiring drug patents would impede the colorectal cancer market growth during the forecast period.
Global Colorectal Cancer Market Taxonomy
The colorectal cancer market is segmented on the basis of therapy, drug, diagnostics and geography.
Request For customization @ https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/request-for-customization
On the basis of therapy, the global colorectal cancer market size is segmented as:
Radiation Therapy
Chemotherapy
Targeted Therapy
Surgery
Others
On the basis of therapy, the global colorectal cancer market size is segmented as:
Bevacizumab (Avastin)
Cetuximab (Erbitux)
Panitumumab (Vectibix)
Regoraferin (Stivarga)
Ziv-Aflibrcept (Zaltrap)
TAS-10 (Lonsurf)
Others
On the basis of therapy, the global colorectal cancer market share is segmented as:
Digital Rectal Examination
Faecal Occult Blood Test
Flexible Sigmoidoscopy
Colonoscopy
Virtual Colonoscopy
Double Contrast Barium Enema
Others
Geographically, the colorectal cancer market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Technological advancement & innovation for screening colorectal cancer to lead the global colorectal cancer market share in North America.
On the basis of geography, North America is expected to dominate the global colorectal cancer market over forecast period. The colorectal cancer market is primarily driven by rising number of aging population in this region, and increasing research & development for new diagnostic methods and innovation of novel drug treatments by the manufacturers. Moreover, high expenditure on healthcare by the government would spur the market of colorectal cancer market in North America.
Browse Complete Report Details @ https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/
Key players in the global colorectal cancer market are:
Amgen Inc.
Bayer AG
Boehringer Inghelheim Inc.
Bristol-Myers Squibb
Merck & Co.
Seimens Healthcare
Epigenomic AG
Clinical Genomics
Beckman Coulter
Abbott Diagnostics
EDP Biotech
Genomic Tree
Metabiomics Corporation.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
Colorectal cancer starts from colon, and is also referred as colon cancer. The cancer cells grow in the inner lining of colon or rectum and these cells are known as polyps. Generally, there are five types of colon cancer namely; Adenocarcinomas, carcinoid tumours, gastrointestinal stromal tumours, lymphomas, and sarcomas. Adenocarcinomas is the most common type of colon cancer that makes up 96% of total colon cancer.
The colorectal cancer spreads into lymph nodes that can be treated with surgical treatment followed by chemotherapy. Colorectal cancer is characterised by bleeding from back passage, losing weight, and pain in your abdomen or back passage. Approximately, 50,000 people die due to this disease every year.
Request sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/request-for-free-sample
According to American Society of Clinical Oncology (ASCO), colorectal is the fourth most common type of cancer in the U.S. In 2017, the number of people suffering from colorectal cancer were 135, 430 adults in the U.S.
Technological advancements in the therapies like chemotherapy to boost the colorectal cancer market.
The colorectal cancer market is primarily driven by the increasing adoption of western diets globally. These diets contain high fats and low fibres leading to the formation of polyps in the colon or rectum. On the other hand, the increasing awareness for treating colorectal cancer by chemotherapy and immunotherapy would also propel the industry growth during the forecast period. While, rise in the aging population, and increasing awareness of consumers in the developing countries will also boost the colorectal market.
However, higher cost of the available treatments, less awareness for ongoing screening test of drugs, and expiring drug patents would impede the colorectal cancer market growth during the forecast period.
Global Colorectal Cancer Market Taxonomy
The colorectal cancer market is segmented on the basis of therapy, drug, diagnostics and geography.
Request For customization @ https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/request-for-customization
On the basis of therapy, the global colorectal cancer market size is segmented as:
Radiation Therapy
Chemotherapy
Targeted Therapy
Surgery
Others
On the basis of therapy, the global colorectal cancer market size is segmented as:
Bevacizumab (Avastin)
Cetuximab (Erbitux)
Panitumumab (Vectibix)
Regoraferin (Stivarga)
Ziv-Aflibrcept (Zaltrap)
TAS-10 (Lonsurf)
Others
On the basis of therapy, the global colorectal cancer market share is segmented as:
Digital Rectal Examination
Faecal Occult Blood Test
Flexible Sigmoidoscopy
Colonoscopy
Virtual Colonoscopy
Double Contrast Barium Enema
Others
Geographically, the colorectal cancer market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Technological advancement & innovation for screening colorectal cancer to lead the global colorectal cancer market share in North America.
On the basis of geography, North America is expected to dominate the global colorectal cancer market over forecast period. The colorectal cancer market is primarily driven by rising number of aging population in this region, and increasing research & development for new diagnostic methods and innovation of novel drug treatments by the manufacturers. Moreover, high expenditure on healthcare by the government would spur the market of colorectal cancer market in North America.
Browse Complete Report Details @ https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/
Key players in the global colorectal cancer market are:
Amgen Inc.
Bayer AG
Boehringer Inghelheim Inc.
Bristol-Myers Squibb
Merck & Co.
Seimens Healthcare
Epigenomic AG
Clinical Genomics
Beckman Coulter
Abbott Diagnostics
EDP Biotech
Genomic Tree
Metabiomics Corporation.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
Contact Information:
Polaris Market Research
Neel
Tel: +1-646-568-9980
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Polaris Market Research
Neel
Tel: +1-646-568-9980
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results